Jain Global’s Aldeyra Therapeutics ALDX Stock Holding History

Jain Global’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$280K	Buy	+131,502	New	+$226K	﹤0.01%	1410

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Jain Global's ALDX Position: Q2 2026 in Review

Jain Global opened a new position in Aldeyra Therapeutics (ALDX) in Q2 2026: 131,502 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #1410 among its holdings.

108 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

Jain Global held 131,502 shares of Aldeyra Therapeutics worth $280K as of Q2 2026.
Aldeyra Therapeutics was a new Jain Global position in Q2 2026.
Aldeyra Therapeutics made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1410 holding.
108 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.